In Committee
Sponsor: Sen. Blackburn, Marsha [R-TN] (R)
Latest Action
Read twice and referred to the Committee on Finance.
Jul 15, 2026
Summary
The bill would modify the Internal Revenue Code to create tax credits for companies that manufacture essential medical supplies and pharmaceuticals within the United States. By incentivizing domestic production, it seeks to strengthen the supply chain and potentially lower costs for patients. The measure is currently referred to the Senate Finance Committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when S 4994 changes status, plus AI-powered summaries and stage predictions.
Sign up free